Protalix BioTherapeutics (PLX) Stock Chart & Stock Price History $3.00 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$3.00 0.00 (-0.17%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Protalix BioTherapeutics Stock Price Performance 5 Day Performance+5.26%1 Month Performance+15.83%3 Month Performance+23.46%6 Month Performance+140.00%Year-To-Date Performance+59.57%1 Year Performance+158.62% Receive PLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address PLX Stock Chart for Friday, May, 2, 2025 PLX Chart by TradingView Protalix BioTherapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$3.07$3.00-2.28%$3.10$2.97556,638 shs$234.10 million04/30/2025$2.96$3.07+3.72%$3.10$2.87914,073 shs$239.56 million04/29/2025$2.85$2.96+3.86%$3.02$2.76674,530 shs$230.98 million04/28/2025$2.85$2.85$2.92$2.76784,914 shs$222.39 million04/25/2025$2.92$2.85-2.23%$3.04$2.84795,410 shs$222.39 million04/24/2025$2.96$2.92-1.52%$3.04$2.881.48 million shs$227.47 million04/23/2025$2.63$2.96+12.55%$2.96$2.692.02 million shs$230.98 million04/22/2025$2.55$2.63+3.14%$2.65$2.60551,899 shs$205.23 million04/21/2025$2.61$2.55-2.30%$2.61$2.50294,920 shs$198.98 million04/18/2025$2.61$2.61$2.64$2.59377,056 shs$203.67 million Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$2.60$2.61+0.38%$2.64$2.59377,056 shs$203.67 million04/16/2025$2.62$2.60-0.76%$2.63$2.55542,896 shs$202.89 million04/15/2025$2.62$2.62$2.66$2.59415,441 shs$204.45 million04/14/2025$2.41$2.62+8.71%$2.63$2.421.00 million shs$204.45 million04/11/2025$2.31$2.41+4.33%$2.43$2.32450,331 shs$188.06 million04/10/2025$2.34$2.31-1.28%$2.34$2.24402,597 shs$180.26 million04/09/2025$2.28$2.34+2.63%$2.41$2.151.13 million shs$182.60 million04/09/2025$2.28$2.34+2.63%$2.41$2.151.13 million shs$182.60 million04/08/2025$2.34$2.28-2.56%$2.48$2.241.04 million shs$177.92 million04/08/2025$2.34$2.28-2.56%$2.48$2.241.04 million shs$177.92 million04/07/2025$2.39$2.34-2.09%$2.46$2.21701,193 shs$182.60 million04/04/2025$2.60$2.39-8.08%$2.57$2.36842,549 shs$186.50 million04/03/2025$2.59$2.60+0.39%$2.60$2.46456,492 shs$202.89 million04/02/2025$2.54$2.59+1.97%$2.61$2.54385,876 shs$202.11 million04/01/2025$2.56$2.54-0.78%$2.59$2.50458,497 shs$198.20 million Related Companies Enliven Therapeutics Stock Price Chart Oculis Stock Price Chart Gyre Therapeutics Stock Price Chart Vir Biotechnology Stock Price Chart Avadel Pharmaceuticals Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Pharvaris Stock Price Chart Xencor Stock Price Chart Anavex Life Sciences Stock Price Chart AbCellera Biologics Stock Price Chart Receive PLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:PLX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLX Stock Free PLX Stock Alerts